Skip to main content
. 2020 Sep 1;164(3):512–518. doi: 10.1177/0194599820954825

Table 3.

Prevalence of Nasal and Chemosensory Symptoms Present in Inpatients With COVID-19 Since the First Day of Symptoms.a

Symptom Total Days 1-3 Days 4-7 Days 8-14 Days 15-55
No. 110 1 20 41 48
Olfactory dysfunction 71 (65.1) 1 (100) 11 (55) 26 (63.4) 31 (64.6)
Taste deficit 73 (66.4) 1 (100) 12 (60) 28 (68.3) 32 (66.7)
Nasal obstruction 25 (22.7) 1 (100) 8 (40) 12 (29.3) 4 (8.4)
Coryza 26 (23.6) 1 (100) 7 (35) 8 (19.5) 10 (20.8)
Nasal yellowish secretion 4 (3.6) 0 2 (10) 0 2 (4.2)
Epistaxis 3 (2.7) 0 0 1 (2.4) 2 (4.2)
Headache 24 (21.8) 1 (100) 7 (35) 8 (19.5) 8 (16.7)
Nasal itching 12 (10.9) 1 (100) 3 (15) 4 (9.8) 5 (10.4)
Posterior rhinorrhea 20 (18.2) 1 (100) 7 (35) 9 (21.9) 4 (8.3)
a

Values are presented as No. (%).